603181.SS
Zhejiang Huangma Technology Co.,Ltd [603181.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603181.SS Stock Summary
Top 10 Correlated ETFs
603181.SS
Top 10 Correlated Stocks
603181.SS
In the News
603181.SS Financial details
Company Rating
Buy
Market Cap
8.54B
Income
461.2M
Revenue
2.28B
Book val./share
4.25
Cash/share
1.48
Dividend
0.1
Dividend %
0.73%
Employees
884
Optionable
No
Shortable
Yes
Earnings
25 Apr 2022
P/E
17.6
Forward P/E
-
PEG
4.06
P/S
3.55
P/B
3.23
P/C
9.28
P/FCF
33.25
Quick Ratio
2.06
Current Ratio
3.54
Debt / Equity
0.32
LT Debt / Equity
0.12
-
-
EPS (TTM)
0.78
EPS next Y
-
EPS next Q
-
EPS this Y
39.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
20.24%
Revenue last 5Y
6.79%
Revenue Q/Q
-20.23%
EPS Q/Q
-50.85%
-
-
-
-
SMA20
-5.69%
SMA50
1.26%
SMA100
-5.99%
Inst Own
-
Inst Trans
-
ROA
14%
ROE
19%
ROC
0.18%
Gross Margin
23%
Oper. Margin
22%
Profit Margin
20%
Payout
15%
Shs Outstand
588.7M
Shs Float
284M
-
-
-
-
Target Price
-
52W Range
12.11-18.48
52W High
-23.67%
52W Low
+14.5%
RSI
27.22
Rel Volume
1.22
Avg Volume
1.76M
Volume
2.15M
Perf Week
-7.16%
Perf Month
-9.07%
Perf Quarter
-13.96%
Perf Half Y
-13.69%
-
-
-
-
Beta
1.06869
-
-
Volatility
0.27%, 0.43%
Prev Close
-2.9%
Price
13.74
Change
-4.25%
603181.SS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
| Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 3.44 | 2.93 | 3.24 | 3.31 | 3.96 | |
| Net income per share | 0.3 | 0.34 | 0.44 | 0.54 | 0.76 | |
| Operating cash flow per share | 0.18 | 0.35 | 0.17 | 0.06 | 0.06 | |
| Free cash flow per share | 0.1 | 0.17 | 0.12 | -0.04 | -0.28 | |
| Cash per share | 0.17 | 0.23 | 0.98 | 1.11 | 1.24 | |
| Book value per share | 2.62 | 2.45 | 2.72 | 3.15 | 3.83 | |
| Tangible book value per share | 2.49 | 2.24 | 2.52 | 2.96 | 3.58 | |
| Share holders equity per share | 2.62 | 2.45 | 2.72 | 3.15 | 3.83 | |
| Interest debt per share | 0.29 | 0.01 | 0 | 0.25 | 0.73 | |
| Market cap | 3.98B | 2.89B | 4.82B | 7.82B | 11.32B | |
| Enterprise value | 4.02B | 2.76B | 4.64B | 7.86B | 11.21B | |
| P/E ratio | 26.97 | 14.67 | 18.8 | 24.41 | 25.24 | |
| Price to sales ratio | 2.37 | 1.68 | 2.54 | 4.02 | 4.84 | |
| POCF ratio | 45.49 | 14.09 | 48.92 | 232.65 | 327.53 | |
| PFCF ratio | 78.65 | 29.88 | 71.04 | -322.21 | -67.32 | |
| P/B Ratio | 3.11 | 2.01 | 3.02 | 4.21 | 5.01 | |
| PTB ratio | 3.11 | 2.01 | 3.02 | 4.21 | 5.01 | |
| EV to sales | 2.39 | 1.6 | 2.45 | 4.04 | 4.8 | |
| Enterprise value over EBITDA | 16.67 | 9.51 | 12.54 | 17.47 | 18.68 | |
| EV to operating cash flow | 45.87 | 13.45 | 47.08 | 234.09 | 324.42 | |
| EV to free cash flow | 79.31 | 28.51 | 68.36 | -324.21 | -66.68 | |
| Earnings yield | 0.04 | 0.07 | 0.05 | 0.04 | 0.04 | |
| Free cash flow yield | 0.01 | 0.03 | 0.01 | 0 | -0.01 | |
| Debt to equity | 0.19 | 0.32 | 0.45 | 0.48 | 0.34 | |
| Debt to assets | 0.16 | 0.24 | 0.31 | 0.33 | 0.26 | |
| Net debt to EBITDA | 0.14 | -0.45 | -0.49 | 0.11 | -0.18 | |
| Current ratio | 3.58 | 5.26 | 3.96 | 3.5 | 3.46 | |
| Interest coverage | 6.99 | 27.83 | 3.53K | 370.44 | 283.58 | |
| Income quality | 0.59 | 1.04 | 0.38 | 0.1 | 0.08 | |
| Dividend Yield | 0 | 0.02 | 0.01 | 0.01 | 0 | |
| Payout ratio | 0.12 | 0.25 | 0.23 | 0.27 | 0.03 | |
| Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | |
| Intangibles to total assets | 0.04 | 0.07 | 0.05 | 0.04 | 0.05 | |
| Capex to operating cash flow | -0.42 | -0.53 | -0.31 | -1.72 | -5.87 | |
| Capex to revenue | -0.02 | -0.06 | -0.02 | -0.03 | -0.09 | |
| Capex to depreciation | -0.68 | -1.88 | -0.4 | -0.69 | -2.39 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.22 | 4.31 | 5.18 | 6.22 | 8.09 | |
| ROIC | 0.14 | 0.13 | 0.14 | 0.13 | 0.26 | |
| Return on tangible assets | 0.1 | 0.11 | 0.12 | 0.12 | 0.16 | |
| Graham Net | -0.22 | -0.44 | -0.14 | -0.27 | 0.13 | |
| Working capital | 590.15M | 740.63M | 807.06M | 872.18M | 1.02B | |
| Tangible asset value | 1.22B | 1.31B | 1.48B | 1.74B | 2.11B | |
| Net current asset value | 572.85M | 460.53M | 358.01M | 326.87M | 652.1M | |
| Invested capital | 0.09 | 0 | 0 | 0.08 | 0.19 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 93.83M | 114.96M | 183.82M | 238.51M | 250.82M | |
| Average inventory | 111.38M | 124.21M | 134.8M | 149.91M | 205.79M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 22.56 | 38.42 | 55.02 | 61.53 | 48.89 | |
| Days of inventory on hand | 30.89 | 35.09 | 33.86 | 39.38 | 49.24 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 16.18 | 9.5 | 6.63 | 5.93 | 7.46 | |
| Inventory turnover | 11.82 | 10.4 | 10.78 | 9.27 | 7.41 | |
| ROE | 0.12 | 0.14 | 0.16 | 0.17 | 0.2 | |
| Capex per share | -0.08 | -0.19 | -0.05 | -0.1 | -0.34 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q3
| Metric | History | 2021-09-30 | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 1.06 | 0.95 | 1.04 | 1.04 | 0.83 | |
| Net income per share | 0.27 | 0.14 | 0.22 | 0.28 | 0.14 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | -0.16 | 0.04 | 0.03 | 0.15 | 0.19 | |
| Cash per share | 1.21 | 1.24 | 1.25 | 1.3 | 1.48 | |
| Book value per share | 3.67 | 3.82 | 4 | 4.11 | 4.25 | |
| Tangible book value per share | 3.42 | 3.57 | 3.75 | 3.87 | 4 | |
| Share holders equity per share | 3.67 | 3.82 | 4 | 4.11 | 4.25 | |
| Interest debt per share | 0.71 | 0.73 | 0.73 | 0.7 | 0.7 | |
| Market cap | 7.6B | 11.33B | 8.46B | 8.91B | 9.17B | |
| Enterprise value | 7.8B | 11.22B | 8.31B | 8.68B | 8.78B | |
| P/E ratio | 11.94 | 34.29 | 16.28 | 13.37 | 27.99 | |
| Price to sales ratio | 12.16 | 20.09 | 13.74 | 14.5 | 18.71 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | -78.17 | 525.52 | 453.95 | 99.75 | 80.65 | |
| P/B Ratio | 3.5 | 5.02 | 3.59 | 3.67 | 3.65 | |
| PTB ratio | 3.5 | 5.02 | 3.59 | 3.67 | 3.65 | |
| EV to sales | 12.49 | 19.9 | 13.48 | 14.12 | 17.92 | |
| Enterprise value over EBITDA | 41.98 | 122.59 | 55.71 | 45.51 | 93.8 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | -80.24 | 520.54 | 445.49 | 97.12 | 77.21 | |
| Earnings yield | 0.02 | 0.01 | 0.02 | 0.02 | 0.01 | |
| Free cash flow yield | -0.01 | 0 | 0 | 0.01 | 0.01 | |
| Debt to equity | 0.38 | 0.34 | 0.38 | 0.34 | 0.32 | |
| Debt to assets | 0.27 | 0.26 | 0.27 | 0.25 | 0.24 | |
| Net debt to EBITDA | 1.09 | -1.17 | -1.06 | -1.23 | -4.17 | |
| Current ratio | 3.89 | 3.46 | 3.46 | 3.41 | 3.54 | |
| Interest coverage | 244.11 | 197.01 | 336.93 | 415.32 | 191.79 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0.01 | 0 | |
| Payout ratio | 0.02 | 0.08 | 0.03 | 0.35 | 0 | |
| Sales general and administrative to revenue | 0.04 | 0 | 0.03 | 0.01 | 0.05 | |
| Research and developement to revenue | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | |
| Intangibles to total assets | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | -0.16 | -0.08 | -0.07 | -0.06 | -0.23 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 4.71 | 3.47 | 4.45 | 5.11 | 3.64 | |
| ROIC | 0.04 | 0.05 | 0.07 | 0.1 | 0.05 | |
| Return on tangible assets | 0.06 | 0.03 | 0.04 | 0.05 | 0.03 | |
| Graham Net | 0.03 | 0.13 | 0.03 | 0.15 | 0.31 | |
| Working capital | 1.07B | 1.02B | 1.14B | 1.09B | 1.08B | |
| Tangible asset value | 2.02B | 2.11B | 2.21B | 2.28B | 2.37B | |
| Net current asset value | 628.43M | 652.1M | 708.48M | 717.08M | 692.22M | |
| Invested capital | 0.19 | 0.19 | 0.18 | 0.17 | 0.16 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 296.09M | 249.19M | 245.64M | 258.05M | 268.13M | |
| Average inventory | 234.56M | 241.89M | 293.57M | 316.86M | 267.27M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 46.15 | 50.61 | 48.25 | 52.51 | 60.63 | |
| Days of inventory on hand | 43.15 | 50.97 | 66.81 | 57.06 | 54.85 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 1.95 | 1.78 | 1.87 | 1.71 | 1.48 | |
| Inventory turnover | 2.09 | 1.77 | 1.35 | 1.58 | 1.64 | |
| ROE | 0.07 | 0.04 | 0.06 | 0.07 | 0.03 | |
| Capex per share | -0.17 | -0.08 | -0.08 | -0.07 | -0.19 |
603181.SS Frequently Asked Questions
What is Zhejiang Huangma Technology Co.,Ltd stock symbol ?
Zhejiang Huangma Technology Co.,Ltd is a CN stock and trading under the symbol 603181.SS
What is Zhejiang Huangma Technology Co.,Ltd stock quote today ?
Zhejiang Huangma Technology Co.,Ltd stock price is $13.74 today.
Is Zhejiang Huangma Technology Co.,Ltd stock public?
Yes, Zhejiang Huangma Technology Co.,Ltd is a publicly traded company.
Company Profile
- Volume Average 1.76M
- Market Capitalization 8.54B
- Employee 884
- Headquarters Shaoxing,CN
- IPO Date 2017-08-24
-
Website
https://www.huangma.com 
Zhejiang Huangma Technology Co.,Ltd researches, develops, produces, and sells surfactants and other products in China. It provides its products for use in new material resins, silicones, lubricants and metalworking fluids, environmental protection coatings, new composite materials, special fibers, agrochemical additives, etc. The company was founded in 2003 and is based in Shaoxing, China.
